Valirx (VAL)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.41p
   
  • Change Today:
      0.000p
  • 52 Week High: 0.88
  • 52 Week Low: 0.23
  • Currency: UK Pounds
  • Shares Issued: 742.72m
  • Volume: 0
  • Market Cap: £3.05m
  • RiskGrade: 435
  • Beta: 0.39

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Gerald Desler 128,668 £528

Major Shareholders

Notifier** Holding Value*
Mark Eccleston 22,746,187 £93,259
Adam Hargreaves 7,749,163 £31,772
SANDERSON CAPITAL PARTNERS LTD 5,000,000 £20,500
Monecor (London) Limited 3,520,629 £14,435
Spreadex Ltd 2,222,840 £9,114
Paul Richards 722,533 £2,962
Cairn Financial Advisers LLP 332,308 £1,362
Jarvis Investment Management Ltd 129,436 £531
Peter James Crowson 3,383 £14

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Valirx Market Data

Currency UK Pounds
Share Price 0.41p
Change Today 0.000p
% Change 0.00 %
52 Week High 0.88
52 Week Low 0.23
Volume 0
Shares Issued 742.72m
Market Cap £3.05m
Beta 0.39
RiskGrade 435

Valirx Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average41.52% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Price Trend
87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average87.83% below the market average
81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average81.82% below the sector average
Income Not Available
Growth
26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average26.62% above the market average
31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average31.03% above the sector average

Valirx Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

Valirx Key Personnel

CFO Gerald Desler

Top of Page